在急性心力衰竭的管理中,不断发展的减压策略
Jeffrey George1,2, W H Wilson Tang2,3,4
1Case Western Reserve University, Cleveland, OH USA.
Current treatment options in cardiovascular medicine
|October 21, 2025
概括
急性心力衰竭 (HF) 管理的新策略包括尿液的导向解和细分性脏阻塞. 这些基于证据的治疗方法改善了患者的治疗结果,减少了住院治疗,并在急性HF护理中提高了生存率.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床实践 临床实践
背景情况:
- 急性心力衰竭 (HF) 是一个重大的临床挑战.
- 有效的管理策略对于改善患者的治疗结果至关重要.
研究的目的:
- 审查急性心力衰竭 (HF) 的最新基于证据的治疗策略.
- 专注于最近的临床试验及其对临床实践的影响.
主要方法:
- 审查最近的临床试验和研究.
- 对急性HF的新兴治疗方式的分析.
主要成果:
- 尿液以为导向的解压证明了在管理流体过载方面的有效性.
- 分段性脏阻塞增强了利尿剂的有效性.
- 改变疾病的疗法和维持性尿液改善了长期的结果,并减少了医院再入院.
结论:
- 基于证据的多方面的方法对于急性HF管理至关重要.
- 实施新的策略,如尿液导向解和细分脏阻塞,可以优化利尿剂治疗.
- 改变疾病的疗法和维持性利尿剂对于改善存活率和预防急性HF中经常性住院至关重要.
相关概念视频
Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796
Heart Failure VII: Nursing Interventions
413
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
413
Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707


